Treasurer of the State of North Carolina’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $171M | Buy |
785,972
+18,838
| +2% | +$4.18M | 0.54% | 27 |
|
|
2025
Q4 | $175M | Sell |
767,134
-29,411
| -4% | -$6.7M | 0.56% | 26 |
|
|
2025
Q3 | $184M | Sell |
796,545
-31,036
| -4% | -$6.32M | 0.57% | 25 |
|
|
2025
Q2 | $154M | Sell |
827,581
-27,645
| -3% | -$5.14M | 0.49% | 29 |
|
|
2025
Q1 | $179M | Sell |
855,226
-36,125
| -4% | -$7.02M | 0.71% | 23 |
|
|
2024
Q4 | $158M | Buy |
891,351
+13,980
| +2% | +$2.57M | 0.62% | 23 |
|
|
2024
Q3 | $173M | Sell |
877,371
-1,603
| -0.2% | -$299K | 0.69% | 20 |
|
|
2024
Q2 | $151M | Buy |
878,974
+9,880
| +1% | +$1.64M | 0.64% | 22 |
|
|
2024
Q1 | $158M | Buy |
869,094
+3,577
| +0.4% | +$616K | 0.69% | 21 |
|
|
2023
Q4 | $134M | Buy |
865,517
+9,927
| +1% | +$1.45M | 0.65% | 21 |
|
|
2023
Q3 | $128M | Buy |
855,590
+596
| +0.1% | +$87.5K | 0.69% | 21 |
|
|
2023
Q2 | $115M | Buy |
854,994
+6,725
| +0.8% | +$986K | 0.6% | 22 |
|
|
2023
Q1 | $135M | Buy |
848,269
+12,143
| +1% | +$1.86M | 0.77% | 20 |
|
|
2022
Q4 | $135M | Buy |
836,126
+28,818
| +4% | +$4.42M | 0.82% | 20 |
|
|
2022
Q3 | $108M | Buy |
807,308
+6,243
| +0.8% | +$896K | 0.72% | 20 |
|
|
2022
Q2 | $123M | Buy |
801,065
+18,742
| +2% | +$2.86M | 0.77% | 20 |
|
|
2022
Q1 | $127M | Buy |
782,323
+6,221
| +0.8% | +$904K | 0.7% | 20 |
|
|
2021
Q4 | $105M | Buy |
776,102
+4,210
| +0.5% | +$497K | 0.55% | 31 |
|
|
2021
Q3 | $83.3M | Buy |
771,892
+2,170
| +0.3% | +$248K | 0.48% | 41 |
|
|
2021
Q2 | $86.7M | Sell |
769,722
-2,800
| -0.4% | -$315K | 0.5% | 33 |
|
|
2021
Q1 | $83.6M | Buy |
772,522
+2,700
| +0.4% | +$289K | 0.53% | 34 |
|
|
2020
Q4 | $82.5M | Buy |
769,822
+3,180
| +0.4% | +$306K | 0.55% | 32 |
|
|
2020
Q3 | $67.2M | Buy |
766,642
+2,859
| +0.4% | +$269K | 0.51% | 37 |
|
|
2020
Q2 | $75M | Buy |
763,783
+28,465
| +4% | +$2.51M | 0.62% | 30 |
|
|
2020
Q1 | $56M | Buy |
735,318
+51,500
| +8% | +$4.39M | 0.5% | 41 |
|
|
2019
Q4 | $60.5M | Buy |
683,818
+6,420
| +0.9% | +$533K | 0.5% | 40 |
|
|
2019
Q3 | $51.3M | Sell |
677,398
-271,390
| -29% | -$18.6M | 0.46% | 49 |
|
|
2019
Q2 | $69M | Sell |
948,788
-21,530
| -2% | -$1.69M | 0.42% | 49 |
|
|
2019
Q1 | $78.2M | Buy |
970,318
+11,831
| +1% | +$968K | 0.5% | 40 |
|
|
2018
Q4 | $88.4M | Buy |
958,487
+12,236
| +1% | +$1.08M | 0.64% | 30 |
|
|
2018
Q3 | $89.5M | Buy |
946,251
+291,936
| +45% | +$27.7M | 0.56% | 34 |
|
|
2018
Q2 | $60.6M | Buy |
654,315
+407,220
| +165% | +$39.8M | 0.63% | 33 |
|
|
2018
Q1 | $23.4M | Buy |
247,095
+242,548
| +5,334% | +$26.6M | 0.61% | 31 |
|
|
2017
Q4 | $440K | Buy |
+4,547
| New | +$429K | 1.08% | 31 |
|
Other funds holding ABBV
VCM
VPM
Treasurer of the State of North Carolina's ABBV Position: Q1 2026 in Review
Treasurer of the State of North Carolina increased its AbbVie (ABBV) stake by 2.5% in Q1 2026, buying an estimated $4.18M and bringing the position to 785,972 shares worth $171M. The position accounts for 0.54% of the portfolio, ranked #27.
Treasurer of the State of North Carolina first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $184M in Q3 2025. 4,091 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Treasurer of the State of North Carolina held 785,972 shares of AbbVie worth $171M as of Q1 2026.
- Treasurer of the State of North Carolina bought 18,838 AbbVie shares in Q1 2026, an estimated $4.18M.
- AbbVie made up 0.54% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #27 holding.
- Treasurer of the State of North Carolina first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Treasurer of the State of North Carolina's AbbVie position peaked at $184M in Q3 2025.
- 4,091 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.